King & Wood Mallesons (KWM) and Tian Yuan advised Sino Biopharmaceutical Limited on its first-time issuance of €750 million zero coupon convertible bonds due 2025. Conyers…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
